我国生物医药领域中生物医学新技术发展及管理现状的思考  

Reflection on the development and management of the biomedical new technology in biomedicine field in China

作　　者：刘家伟 冯佳佳 孔维华 叶青[1] 田杨 董子洵 李科标 林丽开 Jia-Wei LIU;Jia-Jia FENG;Wei-Hua KONG;Qing YE;Yang TIAN;Zi-Xun DONG;Ke-Biao LI;Li-Kai LIN(Wuhan University Hospital Management Institute,Wuhan 430071,China)

机构地区：[1]武汉大学医院管理研究所,武汉430071

出　　处：《医学新知》2023年第2期136-142,共7页New Medicine

摘　　要：生物医药领域在不断发展的同时,对相关技术的需求也在不断提升。生物医学新技术是一类作用于细胞或分子水平的新兴的生物医学技术,是支撑生物医学发展的有力保障。作为一种新的试验性治疗方法,其收益和风险尚需足够的研究检验。我国生物医学新技术近年在相关政策支持下取得了巨大的成就,但该技术目前还存在定义模糊、风险监管缺失等问题。本文介绍了不同领域中生物医学新技术的定义,以生物医药领域中的生物医学新技术为对象,分析我国现有生物医学新技术市场发展和管理现状,以及相关生物技术伴随的风险,并对监管体系提出相应建议。With the continuous development of the biomedical field,the demand for related technologies is also increasing.New biomedical technology is an emerging technology that acts at cell and molecular level and provides the necessary guarantee to support the development of biomedical research.More research is needed to explore the benefits and risks of this new experimental treatment method.China's new biomedical technology has recorded great achievements supported by the relevant policies.Yet it still faces problems including vague definition and lack of risk supervision.This paper introduces the definition of new biomedical technology in different fields,and taking the new biomedical technologies in the field of biomedicine as the object,it analyzes the development of the currently existing market and management status in China.It then discusses the risks associated with such biotechnology and puts forward personal suggestions for a suitable supervision system.

关 键 词：生物医学新技术 生物医学技术 生物医药 生物技术 

分 类 号：R318[医药卫生—生物医学工程]